Stay updated on Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of v3.5.3, indicating a small version update to the page rendering. This appears to be a back-end or UI polish rather than a change to the study details or eligibility information.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page’s revision/update label was incremented from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check61 days agoChange Detected- Added the term 'Adult hepatocellular carcinoma' to the conditions list and removed 'Hepatocellular carcinoma' from the list.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded MeSH term Hepatocellular carcinoma and a Genetic and Rare Diseases Information Center resource; updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Sorafenib with or without SBRT in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib with or without SBRT in Liver Cancer Clinical Trial page.